EIM
CASC

Essex Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Essex Investment Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-153,180
Closed -$567K – 397
2017
Q4 		$567K Buy
+153,180
New +$567K 0.07% 263